05/07/2024
7:30 AM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Rodino Peter W III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:30 AM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
11:16 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form EFFECT | |
05/01/2024
3:35 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 424B5 | |
03/29/2024
8:18 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/27/2024
12:52 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
12:54 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Rodino Peter W III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/22/2024
12:30 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
BRYAN NANCY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
2:01 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
2:01 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Rodino Peter W III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
2:01 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
APPELROUTH STEWART (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
9:37 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form D/A | |
02/09/2024
2:47 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/25/2024
4:00 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2024
12:42 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2024
7:45 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/29/2023
7:15 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
11/20/2023
4:29 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
11/20/2023
8:05 AM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form DFAN14A | |
11/20/2023
6:30 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
11/16/2023
8:21 AM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form DFAN14A | |
11/15/2023
6:30 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2023
3:15 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
11/08/2023
7:45 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2023
5:03 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
11/06/2023
8:09 AM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
| Form DEFC14A | |
10/24/2023
4:00 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form PRER14A | |
10/13/2023
3:57 PM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form PREC14A | |
10/10/2023
8:00 AM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
| Form PREC14A | |
09/29/2023
2:29 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/29/2023
6:00 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/22/2023
8:10 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/28/2023
11:52 AM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form DFAN14A | |
08/28/2023
5:36 AM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
Deutsch Todd (Filed by)
| Form SC 13D/A | |
08/25/2023
1:26 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
12:52 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2023
3:30 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
08/23/2023
7:51 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2023
6:00 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2023
6:20 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2023
3:45 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Protect Your Bank Account Before It’s Too Late (Ad) For months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account.
It gives them the power to monitor every single transaction … Stop right now and do these 3 things to protect yourself |
07/03/2023
7:42 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/30/2023
6:00 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
